Quinapril Hcl And Hydrochlorothiazide Tablet Breastfeeding

Do you know that important immune protective proteins are present in breast milk? Breast milk also contains required vitamins, minerals, saturated and un saturated fats. These things are extremely important for development of healthy brain. If you are taking any medicine for short term or for the chronic reason then that passes in breast milk as well, that is why you should always check the drug with your health care provider. Here at DrLact we try to analyze drugs based on available researches and in this sheet we will present our analysis for Quinapril Hcl And Hydrochlorothiazide Tablet.

What is Quinapril Hcl And Hydrochlorothiazide Tablet used for?


Hypertension: Quinapril Hydrochloride and Hydrochlorothiazide Tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with Quinapril Hydrochloride and Hydrochlorothiazide Tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC). Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly. Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal. Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy. This fixed combination is not indicated for the initial therapy of hypertension (see DOSAGE AND ADMINISTRATION ). In using Quinapril Hydrochloride and Hydrochlorothiazide Tablets, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. Available data are insufficient to show that quinapril does not have a similar risk (see WARNINGS : Neutropenia/Agranulocytosis). Angioedema in Black Patients: Black patients receiving ACE inhibitor monotherapy have been reported to have a higher incidence of angioedema compared to non-blacks. It should also be noted that in controlled clinical trials, ACE inhibitors have an effect on blood pressure that is less in black patients than in non-blacks.

I am currently breastfeeding and I want to know if using Quinapril Hcl And Hydrochlorothiazide Tablet is safe for my kid? Does it have any effect on milk production?

Quinapril Hcl And Hydrochlorothiazide Tablet safe for breastfeeding
There are 2 main ingredients of Quinapril Hcl And Hydrochlorothiazide Tablet, Quinapril and Hydrochlorothiazide. One by one we have analyzed both Quinapril and Hydrochlorothiazide for its impact on breastfeeding and based on our analysis we can conclude that Quinapril Hcl And Hydrochlorothiazide Tablet is safe to use in breastfeeding. We recommend you to check our analysis of Quinapril and Hydrochlorothiazide as below.

Quinapril Hcl And Hydrochlorothiazide Tablet Breastfeeding Analsys


Quinapril while Breastfeeding

Safe

Higher risk on the neonatal period. Check-up for sedation, blood hypotension or weak suction.

Hydrochlorothiazide while Breastfeeding

Safe

CAS Number: 58-93-5

Thiazide diuretic drug. Excretion into breast milk is clinically non-significant. No side-effects were observed in a one-month old breastfed baby whose mother was treated with this medication. Drug level in the plasma of this child was undetectable. Long-term treatment with diuretic drugs (particularly Thiazide type ones with long-lasting effect and loop-acting mechanism) may inhibit lactation, mostly if lactation is not well-established yet. Use as lower dose as possible, especially during the first postnatal month. American Academy of Pediatrics 2013: Maternal Medication Usually Compatible With Breastfeeding. WHO Model List of Essential Drugs 2002: Compatible with breastfeeding.


Quinapril Hcl And Hydrochlorothiazide Tablet Breastfeeding Analsys - 2


Quinapril while Breastfeeding

CAS Number: 85441-61-8

Because of the low levels of quinapril in breastmilk, amounts ingested by the infant are small and would not be expected to cause any adverse effects in breastfed infants.

Hydrochlorothiazide while Breastfeeding

CAS Number: 58-93-5

Hydrochlorothiazide doses of 50 mg daily or less are acceptable during lactation. Intense diuresis with large doses may decrease breastmilk production.


Quinapril Hcl And Hydrochlorothiazide Tablet and breastfeeding

I already used Quinapril Hcl And Hydrochlorothiazide Tablet and meanwhile I breastfed my baby should I be concerned?

Quinapril Hcl And Hydrochlorothiazide Tablet is safe in breastfeeding and should not create any health problem for your baby but in case you feel any health issue associated with Quinapril Hcl And Hydrochlorothiazide Tablet you should contact your doctor or health care provider. Be it pregnancy or lactation you shall keep your doctor informed.


My health care provider has asked me to use Quinapril Hcl And Hydrochlorothiazide Tablet, what to do?

Usage of Quinapril Hcl And Hydrochlorothiazide Tablet is safe for nursing mothers and baby, No worries.


If I am using Quinapril Hcl And Hydrochlorothiazide Tablet, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Quinapril Hcl And Hydrochlorothiazide Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients